Last updated 2026-06-18
- Raised $250k grant, Apr 2023
- Raised funding round, Apr 2023
Total raised
$250K
Last: Grant 2023-04
Stage
Seed
Founded
2023
Headcount
1
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Sonosphere Medical is developing a novel tool for peripheral artery diagnosis (PAD/LEAD) and 3D reconstruction of the organ. Targeting millions of at-risk patients, the company’s patent pending technology incorporates an advanced algorithm to create 3D visualization of the artery.
Funding history · 2 rounds · $250K total
2023-04
Grant
$250K
2023-04
Undisclosed
Q&A
- What is Sonosphere's primary focus?
- Sonosphere Medical is developing a novel tool for peripheral artery diagnosis (PAD/LEAD) and 3D reconstruction of the organ, targeting millions of at-risk patients.
- When was Sonosphere founded?
- Sonosphere was founded in April 2023.
- How much funding has Sonosphere raised to date?
- Sonosphere has raised a total of $250,000 USD.
- Which investors participated in Sonosphere's funding rounds?
- Sonosphere has received funding from G.O Innovation and the Israel Innovation Authority.
- What is the current employee count at Sonosphere?
- Sonosphere has 1-10 employees.
- What is Sonosphere's primary sector?
- Sonosphere's primary sector is Health Tech & Life Sciences.
- What technology does Sonosphere utilize?
- Sonosphere utilizes Simulation & Imaging technology for its diagnostic tool.
- What is the current product stage of Sonosphere?
- Sonosphere's product is currently in the R&D stage.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Simulation & Imaging
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
diagnosticsvascularmedical-devicespatent-pending
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2023-4 |
|---|---|
| Employees (exact) | 1 |
Radar intelligence
Publications (Crossref)
| Works | 1 |
|---|